Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

06. Février 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 11798


	Articles 1 - 20 / 235950

	Relative Clinical Efficacy and Safety of Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Rapid Review and Network Meta-Analysis. J Gastrointest Cancer Sharma S, McConnell D, Carey N, O'Sullivan J, Kearns P, Lowery M, McCullagh L, HEALED Consortium. PMID: 41649630 [PubMed - indexed for MEDLINE]
	Sarcopenia Affects the Clinical Efficacy of Immune Checkpoint Inhibitors in Gastric Cancer Patients: a Systematic Review and Meta-Analysis. J Gastrointest Cancer Zhang F, Yan Y, Li B, Ge C, Wang Y. PMID: 41649620 [PubMed - in process]
	Addressing colorectal cancer screening gaps in Uruguay: a health literacy perspective. Cancer Causes Control Buki LP, Reich M, Abbamonte JM, Sommer RK, Sanabia S, Larrosa D, Sologaistoa B, Blanco M. PMID: 41649617 [PubMed - indexed for MEDLINE]
	A Deep Learning Algorithm for Liver Metastasis Detection at Contrast-enhanced Abdominal CT in Patients with Colorectal Cancer: A Comparative Study with Radiologists. Radiol Imaging Cancer Sartoris R, Paisant A, Bône A, Nicolas F, Malakzadeh S, Matteini F, Dioguardi Burgio M, Vilgrain V, Ronot M, Aubé C. PMID: 41649392 [PubMed - indexed for MEDLINE]
	Systematic Review of Health Insurance and Survival among Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol Martin T, Winegar R, Liu Z. PMID: 41649004 [PubMed - as supplied by publisher]
	Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) tumour expression in gastric carcinoma. Indian J Med Res Kottarathil MS, D'Cruze L, Dhanabal D, K H. PMID: 41648957 [PubMed - indexed for MEDLINE]
	A neural network model delivers a highly prognostic protein signature in cancer stem cells that identifies relapse in stage III colorectal cancer patients. bioRxiv Sturrock A, Cho S, Salvucci M, Sturrock M, Fay J, O'Grady T, McDonough E, Surrette C, Shia J, Firat C, Urganci N, Kisakol B, O'Connell EP, Burke JP, McCawley NM, McNamara DA, Graf JF, McDade SS, Azimi M, Longley DB, Ginty F, Prehn JHM. PMID: 41648468 [PubMed]
	Poor-prognosis young-onset colorectal cancer is defined by the mesenchymal subtype and can be predicted by integrating molecular and histopathological characteristics. ESMO Gastrointest Oncol Ke J, Li Y, Qi L, Li X, Wang W, Hoorn ST, Zhu Y, Huang H, Gao F, Vermeulen L, Wang X. PMID: 41647998 [PubMed]
	Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer-is it justified? ESMO Gastrointest Oncol Peixoto RD, Loree JM, Miranda TA, Solar Vasconcelos JP, Renouf DJ, Davies JM, Gill K, Gill S, Poon V, Metcalf C, Chahal M, Bleszynski MS, Segedi M, Kim PTW, Lim HJ. PMID: 41647996 [PubMed]
	Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study. ESMO Gastrointest Oncol Garcia-Carbonero R, Elez E, García-Alfonso P, Cubillo Gracían A, López López R, Jimenez-Fonseca P, Limón Mirón ML, Dasari A, Lonardi S, Zhu H, Chen L, Yang Z, Schelman WR, Tabernero J. PMID: 41647991 [PubMed]
	Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer. ESMO Gastrointest Oncol Kennecke HF, Zell JA, Pham H, Simianu VV, Herz K, Kelley A, Carmichael JC, Hochster H, Kachnic LA. PMID: 41647990 [PubMed]
	Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations. ESMO Gastrointest Oncol Ros J, Navarro V, Villacampa G, Baraibar I, Salvà F, Rodriguez M, Vaghi C, Garcia A, Alcaraz A, Tabernero J, Élez E, Dienstmann R. PMID: 41647988 [PubMed]
	Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study. ESMO Gastrointest Oncol Ueno H, Kim NK, Kim JC, Tsarkov P, Hohenberger W, Grützmann R, Samalavi, Dulskas A, Liang JT, Quirke P, West N, Shiomi A, Ito M, Shiozawa M, Komori K, Matsuda K, Kinugasa Y, Sato T, Yamada K, Hashiguchi Y, Ozawa H, Kanemitsu Y, Kusumi T, Ike H, Takii Y, Matsuoka H, Toiyama Y, Watanabe J, Ishibe A, Sonoda H, Koda K, Fujita F, Ohue M, Itabashi M, Taketsuna M, Higashide S, Ajioka Y, Sugihara K. PMID: 41647987 [PubMed]
	Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study. ESMO Gastrointest Oncol Koopman M, Garcia-Carbonero R, Pinto C, Mitroshkin A, Bodoky G, Mineur L, Bourgeois V, Mare M, Ruiz-Casado A, Fernandez Montes A, O'Connor JM, Sullivan A, Choucair E, Chevallier B, Marti Marti F, Bachet JB. PMID: 41647985 [PubMed]
	Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab. ESMO Gastrointest Oncol Fakih M, Ciardiello F, Prager GW, Élez E, Calleja E, Caussé-Amellal N, Taieb J, Van Cutsem E. PMID: 41647980 [PubMed]
	WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD). ESMO Gastrointest Oncol Shimozaki K, Hirata K, Hayashi H, Sato Y, Komatsu Y, Taniguchi S, Takahashi N, Yamaguchi K, Furuta M, Kawakami T, Narita Y, Ando T, Makiyama A, Mitani S, Ogata T, Takegawa N, Okamoto W, Nishina T, Komoda M, Hosokawa A, Boku N, Kawakami H, Yamazaki K, Muro K. PMID: 41647978 [PubMed]
	Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study. ESMO Gastrointest Oncol Sartore-Bianchi A, Toscano F, Bernasconi DP, Curaba A, Colombo P, Mazzali C, Piantelli A, Dotti A, Tedesco D, Bencardino K, Amatu A, Tosi F, Bonazzina E, Villa F, Gori V, Piscazzi D, Agostara AG, Calvanese G, Saporetti G, Siena S. PMID: 41647969 [PubMed]
	Fibre, microbes and radiotherapy: unravelling the gut's impact on radiotherapy in cancer. ESMO Gastrointest Oncol Twhigg L, Ng HM, Glyn T, Wall C, Purcell R. PMID: 41647966 [PubMed]
	Comparative analysis of gastric cancer risk attribution (1990-2021) and 2050 burden projection in China, Japan, and South Korea: an age-period-cohort modeling approach based on the Global Burden of Disease 2021 study. Front Oncol Jiang T, Tan L, Dai K. PMID: 41647840 [PubMed]
	Evaluation of computer-aided detection for gastric cancer using white-light and linked-color imaging: a pilot study. IGIE Yasuda T, Ando N, Hashimoto T, Kanai Y, Sakamoto Y, Endo Y, Soda T, Akazawa T, Matsumoto T, Yamauchi N, Muramatsu A, Kutsumi H. PMID: 41647811 [PubMed]

Articles 1 - 20 / 235950

Page 1 de 11798



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité